Skip to main content
Oxford University Press - PMC COVID-19 Collection logoLink to Oxford University Press - PMC COVID-19 Collection
. 2021 Jul 16;79(7):602. doi: 10.1093/ajhp/zxab273

Erratum to: Successful use of early, repeat fecal microbiota transplantation for initial treatment of severe, refractory Clostridioides difficile colitis

Catherine M Cappetto 1,2,
PMCID: PMC9117973  PMID: 34270674

Successful use of early, repeat fecal microbiota transplantation for initial treatment of severe, refractory Clostridioides difficile colitis, Catherine M. Cappetto. Am J Health-Syst Pharm. April 14, 2021 (Case Report).

In the originally published version of this manuscript, the abstract included the following sentence: “A stool sample was collected and resulted positive via by both polymerase chain reaction and enzyme-linked immunosorbent assay for Clostridioides difficile.” This sentence has been corrected online to read: “A stool sample was collected and resulted positive for Clostridioides difficile by both polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA).”

In the originally published version of this erratum, mention of “Clostridioides difficile” was erroneously not italicized and led to the same error in “Successful use of early, repeat fecal microbiota transplantation for initial treatment of severe, refractory Clostridioides difficile colitis”, Catherine M. Cappetto. Am J Health-Syst Pharm. April 14, 2021 (Case Report). This error has now been corrected online only in this erratum and in the abstract summary of “Successful use of early, repeat fecal microbiota transplantation for initial treatment of severe, refractory Clostridioides difficile colitis”.

An error in the title of this erratum has been corrected from: “Correction Notice Erratum to: Successful use of early, repeat fecal microbiota transplantation for initial treatment of severe, refractory Clostridioides difficile colitis” to: “Erratum to: Successful use of early, repeat fecal microbiota transplantation for initial treatment of severe, refractory >Clostridioides difficile colitis”


Articles from American Journal of Health-System Pharmacy: AJHP are provided here courtesy of Oxford University Press

RESOURCES